Items where Division is "Departments > Department of Oncology and Medical Radiology" and Year is 2018

C

Cristofanilli, M. and Slamon, D.J. and Ro, J. and Bondarenko, I. and Im, S-A. and Masuda, N. and Colleoni, M. and DeMichele, A. and Loi, S. and Verma, S. and Iwata, H. and Harbeck, N. and Loibl, S. and Andre´, F. and Puyana Theall, K. and Huang, X. and Giorgetti, C. and Huang Bartlett, C. and Turner, N.C. (2018) Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER22) advanced breast cancer (ABC): Analyses from PALOMA-3. Annals of Oncology, Vol.29 (Sapp.8). viii708-viii708. ISSN 0923-7534 (Print), 1569-8041 (Electronic)

D

Dang, Nam H. and Ogura, Michinori and Castaigne, Sylvie and Fayad, Luis E. and Jerkeman, Mats and Radford, John and Antonio, Antonio and Bondarenko, Igor and Stewart, Douglas A and Shnaidman, Michael and Sullivan, DR. Sharon and Vandendries, Erik and Tobinai, Kensei and Ramchandren, Radhakrishnan and Hamlin, Paul A. and Giné, Eva and Ando, Kiyoshi (2018) Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/ refractory aggressive B-cell non-Hodgkin lymphoma. British Journal of Haematology, 182 (4). pp. 583-586. ISSN 1365-2141

L

Lopes, G. and Wu, Y. and Kudaba, I. and Kowalski, D. and Cho, B. and Turna, H. and De Castro, G. and Srimuninnimit, V. and Laktionov, K. and Bondarenko, I. and Kubota, K. and Lubiniecki, G. and Zhang, J. and Kush, D. and Mok, T. (2018) PS1 Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1%. Journal of Thoracic Oncology, Vol.13 (No. 9S). S152-S154. ISSN 1556-0864

Lopes, G. and Wu, Y. and Kudaba, I. and Kowalski, D. and Cho, B. and Turna, H. and De Castro, G. and Srimuninnimit, V. and Laktionov, K. and Bondarenko, I. and Kubota, K. and Lubiniecki, G. and Zhang, J. and Kush, D. and Mok, T. (2018) Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1%. Journal of Thoracic Oncology, Vol.13 (No.9S). S152-S154.

N

Nekhanevych, O. and Zhyliuk, V. and Logvinenko, V. and Onul, N. and Khomiak, O. (2018) Cardiovascular system and musculoskeletal changes of the sportsmen with polymorphisms of col1a1 gene. Georgian Medical News=Медицинские новости Грузии, 9. pp. 95-99. ISSN 1512-0112

T

Turner, N.C. and Slamon, D.J. and Ro, J. and Bondarenko, I. and Im, S.-A. and Masuda, N. and Colleoni, M. and DeMichele, A. and Loi, S. and Verma, S. and Iwata, H. and Harbeck, N. and Loibl, S. and André, F. and Puyana Theall, K. and Huang, X. and Giorgetti, C. and Huang Bartlett, C. and Cristofanilli, M. (2018) Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer. The New England Journal of Medicine, 379. pp. 1926-1936. ISSN 0028-4793

Z

Zhang, Q. and Xu, B. and Zhang, Q. and Sun, T. and Li, W. and Teng, Y. and Hu, X. and Bondarenko, I. and Adamchuk, H. and Zhang, L. and Trukhin, D. and Wang, S. and Zheng, H. and Tong, Z. and Zhang, X. and Liu, E. and Jiang, W. and Liu, S. and Luk, A. (2018) Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab. Annals of Oncology, Vol.29 (Supp.9). ix16. ISSN 0923-7534 (Print), 1569-8041 (Electronic)

Л

Логвиненко В.В., Державний заклад "Дніпропетровська медична академія Міністерства охорони здоров'я України" (2018) Спосіб ультразвукової діагностики заднього вивиху плеча. u 2017 10794.

С

Слєсаренко, С.В. and Баранов, І.В. and Нор, Н.М. (2018) Лікування рубців шляхом застосування аутоліпографтингу та збагаченої тромбоцитами плазми. ХХІV з’їзд хірургів України [Електронний ресурс]: Зб. наук робіт. Електрон текст. дані. pp. 446-447.